Search results
Regeneron Pharma Outplays Fourth-Quarter Decline, But Sanofi Stock Topples
Investor's Business Daily· 1 year agoRegeneron stock surged Friday on stronger-than-expected metrics, though its partner Sanofi posted a...
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Motley Fool· 10 months agoRegeneron Pharmaceuticals (NASDAQ: REGN) is a leader in the field of therapeutic proteins, with a...
Stock Split Watch: Is Regeneron Pharmaceuticals Next?
Motley Fool· 8 months agoCompanies generally decide to engage in stock splits after their shares have soared to a level that...
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today
Benzinga via Yahoo Finance· 1 year agoSanofi-Regeneron stocks are trading higher today after their blockbuster drug aced the pivotal COPD...
Could Regeneron Pharmaceuticals Stock Help You Become a Millionaire?
Motley Fool· 6 months agoRegeneron Pharmaceuticals (NASDAQ: REGN) is a top pharmaceutical company with many promising assets...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 1 year agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
Investor's Business Daily· 6 months agoRegeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...
Is Regeneron Pharmaceuticals Inc (REGN) Modestly Overvalued?
GuruFocus.com via Yahoo Finance· 10 months agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) reported a daily gain of 1.97% and a 3-month gain of...
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 6 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 3 weeks agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...